A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS).
Saved in:
| Title: | A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS). |
|---|---|
| Authors: | Hasan, Hamza1 (AUTHOR), Deek, Matthew P.1 (AUTHOR), Phillips, Ryan1 (AUTHOR), Hobbs, Robert F.1,2,3 (AUTHOR), Malek, Reem1 (AUTHOR), Radwan, Noura1 (AUTHOR), Kiess, Ana P.1 (AUTHOR), Dipasquale, Shirl1 (AUTHOR), Huang, James1 (AUTHOR), Caldwell, Terry1 (AUTHOR), Leitzel, Jessica1 (AUTHOR), Wendler, Danielle1 (AUTHOR), Wang, Hao2,4 (AUTHOR), Thompson, Elizabeth2 (AUTHOR), Powell, Jonathan2 (AUTHOR), Dudley, Sara1 (AUTHOR), Deville, Curtiland1 (AUTHOR), Greco, Stephen C.1 (AUTHOR), Song, Daniel Y.1,2,5 (AUTHOR), DeWeese, Theodore L.1,2,5 (AUTHOR) |
| Source: | BMC Cancer. 6/1/2020, Vol. 20 Issue 1, p1-13. 13p. 1 Diagram, 2 Charts. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
